ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,170,929 | +79.2% | 79,990 | +103.0% | 0.01% | +66.7% |
| Q2 2023 | $1,211,401 | +76.3% | 39,408 | +106.7% | 0.00% | +50.0% |
| Q1 2023 | $687,019 | -4.5% | 19,068 | +4.7% | 0.00% | 0.0% |
| Q4 2022 | $719,699 | -30.9% | 18,211 | -29.7% | 0.00% | -33.3% |
| Q3 2022 | $1,041,000 | -21.4% | 25,913 | -23.8% | 0.00% | +200.0% |
| Q1 2022 | $1,324,000 | +103.7% | 34,016 | +108.5% | 0.00% | 0.0% |
| Q4 2021 | $650,000 | +22.9% | 16,313 | +11.5% | 0.00% | 0.0% |
| Q3 2021 | $529,000 | -46.1% | 14,637 | -34.9% | 0.00% | -66.7% |
| Q1 2021 | $981,000 | -19.9% | 22,481 | -8.2% | 0.00% | -40.0% |
| Q4 2020 | $1,225,000 | – | 24,479 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |